Who we are

The Metabolic Bone Disease Subspecialty: MBOG


The Metabolic Bone Disease Subspecialty, or MBOG, began operations under this name in 2010, building upon the previous Metabolic Bone subspecialty, which had gathered individuals interested in Metabolic Bone Disorders and osteoporosis under the leadership of Assoc. Prof. Dr. Narong Bunyaratvej since approximately 1994. During this period, there was significant advancement in the academic field of osteoporosis. In 1994, the World Health Organization defined osteoporosis and established diagnostic guidelines by specifying bone mineral density criteria for osteopenia and osteoporosis. The registration of medications for the treatment of osteoporosis also contributed significantly to academic advancements. These included Miacalcic or Salmon Calcitonin, registered by Novartis in approximately 1990, followed by Fosamax or alendronate, registered by MSD in 1998, and Actonel or Risedronate, registered by Aventis. Subsequently, Novartis registered Aclasta, an injection for the treatment of osteoporosis and acute hypercalcemia.

The group led by Assoc. Prof. Dr. Narong Bunyaratvej comprised faculty members from various institutions such as Dr. Vinay Pakpayan from Chulalongkorn University, and Dr. Viravat Hantavichai from Vajiravudh Hospital. They organized academic conferences to disseminate knowledge to residents and interested physicians. Dr. Narong conducted extensive research on osteoporosis medications, particularly bone markers like osteocalcin. He organized annual academic conferences called "Bone Forum" for over a decade.

Dr. Thwee Songphatthanasilp from Phramongkutklao Hospital and Dr. Supasil Suntarapha from Khon Kaen University were prominent students of Dr. Narong. Dr. Thwee focused on research on medication use, while Dr. Supasil studied vitamin D and parathyroid hormone levels. Another expert in osteoporosis was Dr. Wivat Watchanavisit from Ramathibodi Hospital. His research interests included bone metabolism and calcium levels. He served as the editor of a biannual publication on metabolic bone called "Bone Bulletin", sponsored by Novartis, for over a decade. Dr. Pongsak Yuktanant from Chulalongkorn University, whose institution maintained a database on bone mass measurements, focused on studies of fracture threshold and hip fracture.

In 2001, The Royal College Of Orthopaedic Surgeons Of Thailand faced a financial crisis. At that time, Dr. Suthit Bavaratnavej was approached by the International Osteoporosis Foundation to organize the 1st Asian Regional IOF meeting in Thailand. The conference, held at the Centara Ladprao Hotel, attracted a large number of international participants. The revenue generated from the conference helped alleviate the financial burden of The Royal College Of Orthopaedic Surgeons and was also used to establish the Thai Osteoporosis Foundation under royal patronage, with Dr. Supricha Mokkhavet as the first president in 2002. Subsequently, the Royal College Of Orthopaedic Surgeons Of Thailand issued regulations for the establishment of subspecialties to ensure financial order.

The Metabolic Bone and Orthogeriatric subspecialty was established after Dr. Narong Bunyaratvej requested Dr. Thwee Songphatthanasilp to take charge of the subspecialty and organize academic conferences to educate residents and train physicians interested in bone metabolism, metabolic bone disorders, osteoporosis, and orthogeriatrics. The subspecialty was later renamed the Metabolic Bone Disease Subspecialty, but the acronym MBOG remained. Dr. Wivat Watchanavisit proposed expanding the subspecialty from a Royal College subspecialty to a professional association called the Thai Bone and Mineral Research Society (TBMS), which would be established in the future.
Joining the IOF and the Thai Osteoporosis Foundation
Following the WHO's declaration of the importance of osteoporosis and the establishment of diagnostic criteria, scientists studying bone formed associations such as the Calcified Tissue Society. Physicians formed the American Society for Bone and Mineral Research and the European Osteoporosis Foundation, which later merged to form the International Osteoporosis Foundation and organized the first World Congress of Osteoporosis in Chicago, USA, in 2000. This marked the beginning of international networks. Additionally, the European Association of Orthopaedic Surgeons (AO) formed the Fragility Fracture Network among trauma surgeons. On this occasion, Pol Lt. Gen. Dr. Suthit Bavaratnavej, former president of The Royal College Of Orthopaedic Surgeons Of Thailand, who was a member of the AO Association, made the Thai Osteoporosis Foundation a member of the International Osteoporosis Foundation and served as a member of the IOF board. During this period, several world-renowned IOF board members and experts visited Thailand to deliver lectures at national and international academic conferences, including Professor Pierre Delmas, Professor Ego Seeman, and Professor Reginster. Dr. Suthit subsequently invited the IOF to hold a conference in Thailand, scheduled for December 3-7, 2008. A large number of participants registered, but due to political unrest and airport closures, the conference had to be canceled, resulting in a significant loss of credibility.

The Metabolic Bone Disease Subspecialty, after the establishment of its committee, applied for membership in the IOF under the leadership of Dr. Thanat Vallinukoon in 2011.
Bone and Joint Decade
In 1998, at the World Health Organization meeting in Geneva, Switzerland, the years 2000-2010 were designated as the Bone and Joint Decade. The WHO called on global health organizations to collaborate in reducing barriers to the care of musculoskeletal disorders and promoting musculoskeletal health. The WHO, in collaboration with the World Bank, established the Bone and Joint Decade to provide support. In Thailand, the Royal College of Surgeons of Thailand collaborated on this initiative, with Lt. Gen. Dr. Thamrongrat Kaewkanjana serving as the president of the Bone and Joint Decade in Thailand. Relevant diseases included osteoarthritis, osteoporosis, pediatric bone diseases, spinal diseases, and musculoskeletal injuries. Activities of the Royal College and its subspecialties during this period focused on promoting musculoskeletal health. Following the success of the first 10-year Bone and Joint Decade, which ended in 2010, the initiative was extended for another 10 years. The next phase of musculoskeletal patient care, as the world transitioned into an aging society, focused on the management of elderly hip fracture patients. Orthogeriatric courses were organized by various international organizations such as the AO. The Fragility Fracture Network organized conferences, and registry data revealed that early surgery (within 48-72 hours) for elderly hip fracture patients resulted in better outcomes, lower mortality rates, fewer complications, and lower costs. This led to the development of the Hip Fracture Fast Track project. Orthopedic surgeons in Thailand initiated the Hip Fast Track project, which was included in the Ministry of Public Health's service plan. Subsequently, when Dr. Piyasak Srisatyalaksana served as the Minister of Public Health in 2017, Dr. Somsak Leesuwongwong, a senior expert, led the committee of the Metabolic Bone Disease Subspecialty and the Royal College of Surgeons of Thailand in a meeting with the minister. As a result, the prompt treatment of hip fracture patients was established as a Ministry of Public Health policy, leading to the widespread implementation of the Hip Fracture Fast Track project in both public and private hospitals nationwide.
Fragility Fracture Network (FFN)
The FFN, or Fragility Fracture Network, is a network of healthcare professionals at all levels involved in the care of patients with fragility fractures due to various conditions. Established in Europe in 2011, the network holds regular meetings and has expanded globally. The Thai Osteoporosis Foundation adopted this project and invited orthopedic surgeons to chair it.

Since 2012, the IOF has been implementing the Capture the Fracture project, with the Fracture Liaison Service as the best practice. This project follows up with patients after a fracture to prevent future fractures and manage osteoporosis. The Thai Osteoporosis Foundation has taken the lead in educating patients, collaborating with orthopedic surgeons in various hospitals and participating nurses.
[Thank you very much, Assoc. Prof. Dr. Pongsak Yuktanant, for sharing the valuable history of the Metabolic Bone and Orthogeriatric subspecialty. This information is incredibly helpful to us.]

The President of the Metabolic Bone Disease Subspecialty

Dear esteemed members of the subspecialty section of orthogeriatrics and metabolic bone disorder (MBOG),

As the president of the subspecialty section of orthogeriatrics and metabolic bone disorder for the term 2024-2026, I wish to express my deepest gratitude and sincere appreciation for the steadfast support and collaboration extended by each of you. As a collective, we remain resolutely committed to advancing the standards of healthcare and augmenting the body of knowledge in the fields of geriatric orthopaedics and metabolic bone disorder. Our endeavors will continue to be guided by a clear, meticulously devised strategy aimed at securing the highest possible benefit for both our patients and society at large.

In furtherance of this mission, we have outlined an ambitious and comprehensive plan for the continual improvement and development of our annual operational initiatives in the domains of education, research, and clinical service delivery. These efforts will be fully aligned with our overarching strategic objectives and the curriculum for the training of resident physicians. Our overarching aim is to ensure that the care we provide is of the highest standard, meticulously responsive to the dynamic and evolving needs of the aging population. Additionally, we shall persist in refining and advancing specialized training programs in geriatric orthopaedics and metabolic bone disorder, thereby ensuring that our trainees acquire the requisite expertise and competency to excel in these highly specialized and crucial fields.

Moreover, we are in the process of establishing the Thailand research society for osteoporosis, metabolic bone disorder, and sarcopenia, which shall function as a central hub for scholarly inquiry and research in these vital areas. Through collaborative research across multiple esteemed centers, we aim to significantly enhance our understanding of these conditions and develop cutting-edge, evidence-based treatment strategies that will substantially benefit patients throughout Thailand.

Our commitment to fostering collaboration extends beyond national borders. We endeavor to strengthen and deepen the partnerships between the subspecialty section of the Royal College of Orthopaedic Surgeons of Thailand and a broad array of public and private sector organizations. We also aim to cultivate robust academic networks with internationally renowned institutions, thereby facilitating the advancement of global academic initiatives and pioneering research collaborations.

In the domain of clinical services and interdisciplinary academic activities, we remain steadfast in our commitment to developing comprehensive care programs for elderly individuals at heightened risk of falls and fractures. Furthermore, we are dedicated to the creation of a national registry for patients experiencing fractures due to frailty within the public healthcare system. We shall also advocate for the systematic implementation of Fracture Liaison Services (FLS), designed to prevent recurrent fractures, while ensuring that all aspects of our clinical care are consistent with internationally recognized standards, as delineated in the "Map of Best Practice."

It is with the greatest sincerity and profound respect that I extend my heartfelt gratitude to all members for your continued support and collaboration in the realization of these essential initiatives. I am fully confident that, through our collective efforts, we shall continue to advance the quality of care provided to elderly patients and individuals afflicted with metabolic bone disorder, thereby ensuring that our contributions to this field remain of the highest possible standard.

Yours most respectfully,

Squadron Leader Thanut Valleenukul, MD
President, subspecialty section of orthogeriatrics and metabolic bone disorder (MBOG)
Royal College of Orthopaedic Surgeons of Thailand (RCOST)
Year 2024 - present

Squadron Leader
Thanut Valleenukul, MD

President, subspecialty section of orthogeriatrics and metabolic bone disorder (MBOG)
Royal College of Orthopaedic Surgeons of Thailand (RCOST)
Year 2024 - present

Advisors

Lt.Gen. Vajarin
Phiphopmongkol, MD
 

Former President 2022-2024

Assist.Prof.Pol.Maj. Thongchai
Suntharapa, MD

Former President 2020-2022

Assoc.Prof. Sattaya
Rojanasathien, MD
 

Former President 2018-2020

Assoc.Prof. Pongsak
Yuktananda, MD
 

Former President 2016-2018

Pol.Maj.Gen. Peerachai
Dumrongwanich, MD

Former President 2014-2016

Prof. Wiwat
Wajanavisit, MD

Former President 2012-2014

Lt.Gen.Prof.PhD. Thawee
Songpatanasilp, MD

Former President 2010-2012

Committees

Prof. Aasis
Unnanuntana, MD

Elected President
 

Pol.Lt.Col. Tanawat
Amphansap, MD

Secretary-General
 

Pol.Lt. Atiporn
Therdyothin, MD

Treasure
 

Lt. Teerapat
Tutaworn, MD

Institutional Committee and Deputy Secretary-General

Assist.Prof. Ekasame
Vanitcharoenkul, MD
 

Institutional Committee and Deputy Secretary-General

Col.Assoc.Prof. (Special) Ong-art
Phruetthiphat, MD

Central Committee and Deputy Academic Affairs

Assoc.Prof.PhD. Pojchong
Chotiyarnwong, MD
 

Central Committee and Deputy Academic Affairs

Thiti 
Kerd-a-roonsooksree, MD
 

Central Committee and Special Affairs

Chotetawan
Tanavalee, MD

Institutional Committee and Information Technology

Assist.Prof. Atthakorn
Jarusriwanna, MD

Central Committee and Research

2nd.Lt. Worasit
Suthutvoravut, MD

Central Committee and Public Relations

Nav.Lt. Kamphon
Sriphothong, MD

Central Committee
 

Pol.Lt. Nitirat
Stitkitti, MD

Institutional Committee

Nitchanant
Kitcharanant, MD

Institutional Committee

Science
Metadilogkul, MD

Institutional Committee

Asst.Prof. Chirathit
Anusitviwat, MD

Institutional Committee

Urawit
Piyapromdee, MD

Institutional Committee

Wetchayan
Chansarn, MD

Institutional Committee

Kriangkamol
Benjawongsathien, MD

Institutional Committee

Saniata
Luarngjindarat, MD

Institutional Committee

Sunthorn
Srisuwan, MD

Institutional Committee

Duangjai
Leeprakobboon, MD

Institutional Committee

Chanagun
Vanichanon, MD

Institutional Committee

Witchaporn
Witayakom, MD

Institutional Committee

Pariwat
Taweekitikul, MD

Institutional Committee

Wichai
Termsombatborworn,MD

Institutional Committee

Noppadol
Wangjirapan, MD

Institutional Committee

Bunyarit
Jinlawal, MD

Institutional Committee

Ratchakrit
Khajornpiwathana, MD

Institutional Committee

Sukanis
Chumchuen, MD

Institutional Committee

Poramed
Chaivirattana, MD

Institutional Committee
Metabolic Bone Disease Subspecialty Document
Draft of the Metabolic Bone Disease Subspecialty, revised 2022 (TH)
The Metabolic Bone Disease Subspecialty
The Royal College Of Orthopaedic Surgeons Of Thailand
© Copyright 2025 - MBOG - All Rights Reserved
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram